• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. FMC BLOODLINE; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. FMC BLOODLINE; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number UNKNOWN- FMC BLOODLINE
Device Problem Fluid/Blood Leak (1250)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 03/23/2024
Event Type  malfunction  
Event Description
A user facility clinic manager (cm) reported to fresenius that a blood leak occurred with the fresenius dialyzer and bloodline set during the patient's hemodialysis (hd) treatment.The reported issue occurred 26 minutes after treatment initiation.The registered nurse (rn) visually observed blood leaking at the connection between the bloodline set and the venous side of the dialyzer.The rn attempted to tighten the connection but the leak continued.The 2008t machine was re-primed with new supplies to resolve the reported issue.Additional information was obtained during follow-up.There was no defect or damage noted to either product.No issues were encountered during prime.There was no serious injury or required medical intervention as a result of the reported issue.The patient's estimated blood loss (ebl) could not be provided.Treatment was restarted and successfully completed on the same machine with new supplies.The samples are available to be retuned to the manufacturer for physical evaluation.
 
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event Description
A user facility clinic manager (cm) reported to fresenius that a blood leak occurred with the fresenius dialyzer and bloodline set during the patient's hemodialysis (hd) treatment.The reported issue occurred 26 minutes after treatment initiation.The registered nurse (rn) visually observed blood leaking at the connection between the bloodline set and the venous side of the dialyzer.The rn attempted to tighten the connection but the leak continued.The 2008t machine was re-primed with new supplies to resolve the reported issue.Additional information was obtained during follow-up.There was no defect or damage noted to either product.No issues were encountered during prime.There was no serious injury or required medical intervention as a result of the reported issue.The patient's estimated blood loss (ebl) could not be provided.Treatment was restarted and successfully completed on the same machine with new supplies.The samples are available to be retuned to the manufacturer for physical evaluation.
 
Manufacturer Narrative
Plant investigation: the sample was not returned to the manufacturer and the lot number was not provided.A manufacturing review was performed on the products shipped to the customer for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius combiset bloodlines shipped to this account within the selected time frame.The entire set of lots have been sold and distributed.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.An investigation of the device history records (dhr) was conducted and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The product lots involved met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FMC BLOODLINE
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
director, quality systems
900 w zaragosa drive suite d
pharr TX 78577
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key19023267
MDR Text Key339245771
Report Number0008030665-2024-00320
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/02/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN- FMC BLOODLINE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received04/23/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS DIALYZER; FRESENIUS DIALYZER
Patient Age75 YR
Patient SexMale
Patient Weight56 KG
-
-